Evidence map›Paper›PMID 32345272›Full record

ArticleBMC complementary medicine and therapies2020

In vitro enzyme inhibitory and cytotoxic studies with Evolvulus alsinoides (Linn.) Linn. Leaf extract: a plant from Ayurveda recognized as Dasapushpam for the management of Alzheimer's disease and diabetes mellitus.

Pavithra Mettupalayam Kaliyannan Sundaramoorthy, Kannan Kilavan Packiam

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Mechanistic insights intoFood chemistry: X · 2026
    Article
  3. Article
  4. Phytochemical Screening and Antidiabetic Activity of Aqueous Extract ofJournal of pharmacy & bioallied sciences · 2024
    Article
  5. Exploring the neuropharmacological properties of scopoletin-richAmerican journal of translational research · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Foods (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pavithra Mettupalayam Kaliyannan SundaramoorthyDepartment of Biotechnology, Bannari Amman Institute of Technology, Sathyamangalam, Tamilnadu, India. pavithramks@bitsathy.ac.in.
Kannan Kilavan PackiamDepartment of Biotechnology, Bannari Amman Institute of Technology, Sathyamangalam, Tamilnadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvolvulus alsinoides (Linn.) Linn. (Convolvulaceae) is a therapeutic herb alleviating brain patterns associated with three categories of regulatory principles of the body, mind, and behaviour. In the current research, enzyme inhibition and cytotoxic potentials of E. alsinoides (L.) L. leaf extract has been studied validating its potential application.

methodsThe plant phenolics in the leaf extracts obtained via cold-maceration with solvents viz.: n-hexane, chloroform, ethyl acetate, methanol, and water were quantitatively analyzed. The antioxidant potency was evaluated using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and Ferric Reducing Ability of Plasma (FRAP) assays at five concentrations (100-500 μg). The enzyme inhibition potential was performed with α-amylase, α-glucosidase, and acetylcholinesterase at seven concentrations (25-500 μg). The experiments were done in triplicates and statistically validated using Minitab-17 and SPSS 22.

resultsWater extract contain 45.08 ± 0.02 mg GAE/g, 49.30 ± 0.07 mg GAE/g, 211.21 ± 0.02 mg QE/g tannins, phenolics, flavonoids respectively. Its antioxidant activity was supported by IC DISCUSSION AND

conclusionsThe extracts with potent antioxidant and enzyme-inhibiting activity were determined. The findings of the research are the first report about the inhibition effects of Evolvulus alsinoides (Linn.) Linn extracts against α-amylase, α-glucosidase and acetylcholinesterase. The extracts shall be examined in future studies to evaluate its pharmaceutical potential.

Indexed as

Acetylcholinesterasealpha-Amylasesalpha-GlucosidasesAlzheimer DiseaseCell Line, TumorCholinesterase InhibitorsConvolvulaceaeDiabetes MellitusGlycoside Hydrolase InhibitorsHumansIndiaMedicine, AyurvedicPlant ExtractsPlant LeavesAcetylcholinesterasealpha-Amylasesalpha-GlucosidasesCholinesterase InhibitorsGlycoside Hydrolase InhibitorsPlant ExtractsAlzheimer’s diseaseBioactivityEnzyme inhibitionEvolvulus alsinoides (Linn.) Linn.HyperglycemiaNeuroblastoma cell linesNeuronal disorderPearson correlation

Identifiers

PMID32345272
PMCPMC7189705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.